Structure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 4221-4236

  Mirza, Zeenat ^a,b   Pillai, Vikram Gopalakrishna ^b,c   Zhong, Wei Zhu ^d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Co crystallization; Cobra venom; DAEFRHDS; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; BEE VENOM; PHOSPHOLIPASE A2; SNAKE VENOM; PROTEIN BINDING;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG POTENTIATION; ENZYME ACTIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NAJA NAJA; NAJA NAJA SAGITTIFERA; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN AGGREGATION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY; ANIMAL; BINDING SITE; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; HUMAN; HYDROGEN BOND; METABOLISM; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; BINDING SITES; COBRA VENOMS; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; PHOSPHOLIPASES A2; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84896484260     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15034221     Document Type: Article

References (46)

1. Pouryamout, L.; Dams, J.; Wasem, J.; Dodel, R.; Neumann, A. Economic evaluation of treatment options in patients with Alzheimer's disease: A systematic review of cost-effectiveness analyses. Drugs 2012, 72, 789-802.
2. Israel, M. A.; Yuan, S. H.; Bardy, C.; Reyna, S. M.; Mu, Y.; Herrera, C.; Hefferan, M. P.; van Gorp, S.; Nazor, K. L.; Boscolo, F. S.; et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482, 216-220.
3. Young, J. E.; Goldstein, L. S. Alzheimer's disease in a dish: Promises and challenges of human stem cell models. Hum. Mol. Genet. 2012, 21, R82-R89.
4. Silvestrelli, G.; Lanari, A.; Parnetti, L.; Tomassoni, D.; Amenta, F. Treatment of Alzheimer's disease: From pharmacology to a better understanding of disease pathophysiology. Mech. Ageing Dev. 2006, 127, 148-157.
5. Craft, J. M.; Watterson, D. M.; van Eldik, L. J. Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 2006, 53, 484-490.
6. Stuchbury, G.; Munch, G. Alzheimer's associated inflammation, potential drug targets and future therapies. J. Neural Transm. 2005, 112, 429-453.
7. Landau, M.; Sawaya, M. R.; Faull, K. F.; Laganowsky, A.; Jiang, L.; Sievers, S. A.; Liu, J.; Barrio, J. R.; Eisenberg, D. Towards a pharmacophore for amyloid. PLoS Biol. 2011, 9, e1001080.
8. Querfurth, H. W.; LaFerla, F. M. Alzheimer's disease. N. Engl. J. Med. 2010, 362, 329-344.
9. Vassar, R.; Bennett, B. D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E. A.; Denis, P.; Teplow, D. B.; Ross, S.; Amarante, P.; Loeloff, R.; et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286, 735-741.
10. Jarrett, J. T.; Berger, E. P.; Lansbury, P. T., Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32, 4693-4697.
11. Murakami, M.; Kudo, I. Phospholipase A2. J. Biochem. 2002, 131, 285-292.
12. Moses, G. S.; Jensen, M. D.; Lue, L. F.; Walker, D. G.; Sun, A. Y.; Simonyi, A.; Sun, G. Y. Secretory PLA2-IIA: A new inflammatory factor for Alzheimer's disease. J. Neuroinflamm. 2006, 3, 28.
13. Chalbot, S.; Zetterberg, H.; Blennow, K.; Fladby, T.; Andreasen, N.; Grundke-Iqbal, I.; Iqbal, K. Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease. J. Alzheimers Dis. 2011, 25, 505-515.
14. Kolko, M.; Christoffersen, N. R.; Barreiro, S. G.; Miller, M. L.; Pizza, A. J.; Bazan, N. G. Characterization and location of secretory phospholipase A2 groups IIE, V, and X in the rat brain. J. Neurosci. Res. 2006, 83, 874-882.
15. Singh, R. K.; Singh, N.; Jabeen, T.; Sharma, S.; Dey, S.; Singh, T. P. Crystal structure of the complex of group I PLA2 with a group II-specific peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) at 2. 6 Å resolution. J. Drug Target. 2005, 13, 367-374.
16. Carter, D. B.; Chou, K. C. A model for structure dependent binding of Congo Red to Alzeheimer beta-amyloid fibrils. Neurobiol. Aging 1998, 19, 37-40.
17. Chou, K. C. Insights from modelling the tertiary structure of BACE2. J. Proteome Res. 2004, 3, 1069-1072.
18. Chou, K. C.; Howe, W. J. Prediction of the tertiary structure of the beta-secretase zymogen. Biochem. Biophys. Res. Commun. 2002, 292, 702-708.
19. Gu, R. X.; Gu, H.; Xie, Z. Y.; Wang, J. F.; Arias, H. R.; Wei, D. Q.; Chou, K. C. Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. Med. Chem. 2009, 5, 250-262.
20. Zheng, H.; Wei, D. Q.; Zhang, R.; Wang, C.; Wei, H.; Chou, K. C. Screening for new agonists against Alzheimer's disease. Med. Chem. 2007, 3, 488-493.
21. Chou, K. C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem. 2004, 11, 2105-2134.
22. Berardi, M. J.; Shih, W. M.; Harrison, S. C.; Chou, J. J. Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching. Nature 2011, 476, 109-113.
23. OuYang, B.; Xie, S.; Berardi, M. J.; Zhao, X. M.; Dev, J.; Yu, W.; Sun, B.; Chou, J. J. Unusual architecture of the p7 channel from hepatitis C virus. Nature 2013, 498, 521-525.
24. Schnell, J. R.; Chou, J. J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008, 451, 591-595.
25. Laskowski, R.; Macarthur, M.; Moss, D.; Thornton, J. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-290.
26. Ramachandran, G. N.; Sasisekharan, V. Conformation of polypeptides and proteins. Adv. Protein Chem. 1968, 23, 283-438.
27. Singh, N.; Kumar, R. P.; Kumar, S.; Sharma, S.; Mir, R.; Kaur, P.; Srinivasan, A.; Singh, T. P. Simultaneous inhibition of anti-coagulation and inflammation: Crystal structure of phospholipase A2 complexed with indomethacin at 1. 4 Å resolution reveals the presence of the new common ligand-binding site. J. Mol. Recognit. 2009, 22, 437-445.
28. Berg, O. G.; Yu, B. Z.; Rogers, J.; Jain, M. K. Interfacial catalysis by phospholipase A2: Determination of the interfacial kinetic rate constants. Biochemistry 1991, 30, 7283-7297.
29. Yu, B. Z.; Berg, O. G.; Jain, M. K. The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2. Biochemistry 1993, 32, 6485-6492.
30. Jones, D. T. Predicting novel protein folds by using FRAGFOLD. Proteins 2001, 45, 127-132.
31. Hegler, J. A.; Latzer, J.; Shehu, A.; Clementi, C.; Wolynes, P. G. Restriction versus guidance in protein structure prediction. Proc. Natl. Acad. Sci. USA 2009, 106, 15302-15307.
32. Lustbader, J. W.; Cirilli, M.; Lin, C.; Xu, H. W.; Takuma, K.; Wang, N.; Caspersen, C.; Chen, X.; Pollak, S.; Chaney, M.; et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304, 448-452.
33. Shen, Y.; Joachimiak, A.; Rosner, M. R.; Tang, W. J. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 2006, 443, 870-874.
34. Hoyer, W.; Hard, T. Interaction of Alzheimer's A beta peptide with an engineered binding protein-Thermodynamics and kinetics of coupled folding-binding. J. Mol. Biol. 2008, 378, 398-411.
35. Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Dobeli, H.; Schubert, D.; Riek, R. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA 2005, 102, 17342-17347.
36. Miles, L. A.; Wun, K. S.; Crespi, G. A.; Fodero-Tavoletti, M. T.; Galatis, D.; Bagley, C. J.; Beyreuther, K.; Masters, C. L.; Cappai, R.; McKinstry, W. J.; et al. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope. J. Mol. Biol. 2008, 377, 181-192.
37. Watson, A. A.; Fairlie, D. P.; Craik, D. J. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? Biochemistry 1998, 37, 12700-12706.
38. Coles, M.; Bicknell, W.; Watson, A. A.; Fairlie, D. P.; Craik, D. J. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 1998, 37, 11064-11077.
39. Castelletto, V.; Hamley, I. W.; Harris, P. J.; Olsson, U.; Spencer, N. Influence of the solvent on the self-assembly of a modified amyloid beta peptide fragment. I. Morphological investigation. J. Phys. Chem. B 2009, 113, 9978-9987.
40. Davis, C. H.; Berkowitz, M. L. Structure of the amyloid-beta (1-42) monomer absorbed to model phospholipid bilayers: A molecular dynamics study. J. Phys. Chem. B 2009, 113, 14480-14486.
41. Singh, R. K.; Vikram, P.; Makker, J.; Jabeen, T.; Sharma, S.; Dey, S.; Kaur, P.; Srinivasan, A.; Singh, T. P. Design of specific peptide inhibitors for group I phospholipase A2: Structure of a complex formed between phospholipase A2 from Naja naja sagittifera (group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1. 9 Å resolution reveals unique features. Biochemistry 2003, 42, 11701-11706.
42. Reynolds, L. J.; Hughes, L. L.; Yu, L.; Dennis, E. A. 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal. Biochem. 1994, 217, 25-32.
43. Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276, 307-326.
44. Navaza, J. AmoRe: An automated package for molecular replacement. Acta Crystallogr. A 1994, 50, 157-163.
45. Murshudov, G. N.; Dodson, E. J. Simplified error estimation a la Cruickshank in macromolecular crystallography. CCP4 Newslett. Protein Crystallogr. 1997, 33, 31-39.
46. Jones, T. A.; Zou, J. Y.; Cowan, S. W.; Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 1991, 47, 110-119.